Myocardial infarction and cardiac mortality in the bypass angioplasty revascularization investigation (BARI) randomized trial

Circulation

Volumn 96, Issue 7, 1997, Pages 2162-2170

  Chaitman, Bernard R ^a   Rosen, Allan D ^a   Williams, David O ^a   Bourassa, Martial G ^a   Aguirre, Frank V ^a   Pitt, Bertram ^a   Rautaharju, Pentti M ^a   Rogers, William J ^a   Sharaf, Barry ^a   Attubato, Michael ^a   Hardison, Regina M ^a   Srivatsa, Sanjay ^a   Kouchoukos, Nicholas T ^a   Stocke, Karen ^a   Sopko, George ^a   Detre, Katherine ^a   Frye, Robert ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; FEMALE; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

EID: 9844266802     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.7.2162     Document Type: Article

References (34)

1. Bourassa MG, Roubin OS, Dctre KM, Sopko G, Krone RJ, Attubato MJ, Bjerregaard P, Boiling S, Herman MV, Frye R, and the BARI Study Group. Bypass Angioplasty Revascularization Investigation: patient screening, selection, and recruitment. Am J Cardiol. 1995;75:3C-8C.
2. Rogers WJ, Alderman EL, Chaitman BR, DiSciascio G, Horan M, Lytle B, Mock BM, Rosen AD, Sutton-Tyrrell K, Weiner BH, Whitlow PL, and the BARI Study Group. Bypass Angioplasty Revascularization Investigation (BARI): baseline clinical and angiographie data. Am J Cardiol. I995;75:9C-17C.
3. Protocol for the Bypass Angioplasty Revascularization Investigation. Circulation. 1991;84(suppl V):V-l-V-27.
4. Alderman EL, Anrews K, Bourassa MG, Brooks MM, Chaitman BR, Detre K, Faxon DP/Follman D, Frye RL, Hlatky M, Jones RH, Kelsey SF, Rogers WJ, Rosen AD, Schaff H, Sellers MA, Sopko G, Sutton-Tyrell K, Williams DO, on behalf of the Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Five-year clinical and functional outcome in a multicenter randomized trial comparing bypass surgery and angioplasty in patients with multivessel disease. JAMA. 1997;277:715-721.
5. Hlatky MA, Rogers WJ, Johnstone I, Boothroyd D, Brooks MM, Pitt B, Reeder G, Ryan T, Smith H, Whitlow P, Wiens RD, Mark DB, Rosen AD, Detre KM, Frye RL, for the Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. N EnglJ Med. 1997;336: 92-97.
6. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med. 1996;335: 217-225.
7. The BARI Investigators. The influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI). Circulation. In press.
8. Pocock SJ, Henderson RA, Rickards A, Hampton JR, King SB, Hamm CW, Fuel J, Hueb W, Goy JJ, Rodriguez A. Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery. Lancet. 1995;346:1184-1189.
9. Hamm CW, Reimers J, Ischinger T, Rupprecht HJ, Berger J, Bleifeld W, for the German Angioplasty Bypass Surgery Investigation. A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. N Engl J Med. 1994;331:1037-1043.
10. RITA Trial Participants. Coronary angioplasty versus coronary artery bypass surgery: the Randomised Intervention Treatment of Angina (RITA) trial. Lancet. 1993;341:573-5SO.
11. King SB, Lembo NJ, Weintraub WS, Kosinski AS, Barnhart HX, Kutner MH, Alazraki NP, Guyton RA, Zhao XQ, for the Emory Angioplasty versus Surgery Trial (EAST). A randomized trial comparing coronary angioplasty with coronary bypass surgery. N Engl J Med. 1994;331:1044-1050.
12. CABRI Trial Participants. First-year results of the CABRI (Coronary Angioplasty versus Bypass Revascularization Investigation). Lancet. 1995;346:1179-1184.
13. King SB, Lembo NJ, Weintraub WS, Kosinski AS, Barnhart HX, Kutner MH, for the EAST Investigators. Emory Angioplasty versus Surgery Trial (EAST): design, recruitment, and baseline description of patients. Am J Cardiol. 1995;75:42C-59C.
14. Prineas RJ, Crow RS, Blackburn H. Tlie Minnesota Code Manual of Electrocardiographic Findings: Standards and Procedures for Measurement and Classification. Wright J, ed. Boston, Mass: John Wright. PSG Inc; 1982:1-229.
15. Rautaharju PM, Calhoun HP, Chaitman BR. NOVACODE serial ECG classification system for clinical trials and epidemiologic studies. J Electrocardiol. 1992;24:179-187.
16. Chaitman BR, Zhou SH, Tamesis B, Rosen A, Terry AB, Zumbehl KM, Stocke K, Takase B, Gussak I, Rautaharju PM. Methodology of serial ECG classification using an adaptation of the NOVACODE for Q wave myocardial infarction in the Bypass Angioplasty Revascularization Investigation (BARI). J Electrocardiol. 1996;29:265-277.
17. Chaitman BR, Alderman EL, Sheffield LT, Tong T, Fisher L, Mock MB, Wiens RD, Kaiser GC, Roitman D, Berger R, Gersh B, Schaff H, Bourassa MG, Killip T, and Participating CASS Medical, Centers. Use of survival analysis to determine the clinical significance of new Q waves after coronary bypass surgery. Circulation. 1983;67:302-309.
18. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
19. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. / Natl Cancer Inst. 1959;22: 719-748.
20. Cox DR. Regression models and life-tables. J R Stat Soc (B). 1972;34:187-220.
21. Ryan TJ, Bauman WB, Kennedy JW, Kereiakes DJ, King SB, McCallister BD, Smith SC Jr, Ullyot DJ. Guidelines for percutaneous coronary angioplasty: a report from the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Pro-cedures (Committee on Percutaneous Transluminal Coronary Angioplasty). Circulation. 1993;88:29S7-3007.
22. Detre K, Yeh W, Kelsey S, Williams D, Desvigne-Nickens P, Holmes D, Bourassa M, King S, Faxon D, Kent K, for the Investigators of the NHLBI Percutaneous Transluminal Coronary Angioplasty Registry. Has improvement in PTCA intervention affected long-term prognosis? The NHLBI PTCA registry experience. Circulation. 1995;91:286S-2875.
23. CASS Principal Investigators and their Associates. Myocardial infarction and mortality in the Coronary Artery Surgery Study (CASS) randomized trial. N Engl J Med. 1984;310:750-758.
24. Chaitman BR, Jaffe AS. What is the true periprocedure myocardial infarction rate? Does anyone know for sure? The need for clarification. Circulation. 1995;91:1609-1610.
25. Califf RM, Abdelmeguid A, Kuntz R, Popma JJ, Tardiff BE, Crenshaw B, Bauman RP, Davidson CJ, Cohen EA, Kleiman NS, Mahaffey KW, Topol EJ, Pepine CJ, Lipicky R, Granger CB, Harrington RA, Zuckerman B, Chaitman BR, Bittl JA, Ohman EM. Myonecrosis after revascularization procedures. / Am Coll Canliol. In press.
26. Ohman EM, Armstrong PW, Christenson RH, Granger CB, Katus HA, Hamm CW, O'Hanesian MA, Wagner GS, Kleiman NS, Harrell FE, Califf RM, Topol EJ, for the GUSTO-IIa Investigators, Cardiac troponin T levels for risk stratification in acute myocardial ischemia. N Engl J Med. 1996;335:1333-1341.
27. Antman EM, Tanasijevic MJ, Thompson B, Schactman M, McCabe CH, Cannon CP, Fischer GA, Fung AY, Thompson C, Wybenga D,
28. Braunwald E. Cardiac-specific troponin I levels to predict the risk of mortality in patients with, acute coronary syndromes. N Engl J Med. 1996;335:1342-1349.
29. Sigurdsson E, Thorgeirss'on G, Sigvaldason H, Sigfusson N. Unrecognized myocardial infarction: epidemiology, clinical characteristics, and the prognostic role of angina pectoris-The Reykjavik Study. Ann Intern Med. 1995:122:96-102.
30. Kannel WB, Abbott RD. Incidence and prognosis of unrecognized myocardial infarction: an update on the Framinaham sludy.NEngl JMed. 1984;311:1144-1147.
31. Karnegis JN, Matts J, Tuna N. Development and evolution of electrocardiographic Minnesota Q-QS codes in patients with acute myocardial infarction. Am Heart J. 1985;110:452-459.
32. Serruys PW, de Jaegere P, Kiemenij F, Macaya C, Rutsch W, Hendrickx G, Emanuelsson H, Marco J, Legrand V, Materne P, Belardi J, Sigwart U, Colombo A, Goy J, Van Den Heuvel P, Delca J, Morel M, for the Benestent Study Group. A comparison between balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease: Benestent Study Group. N Engl J Med. 1994;331:489-495.
33. EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein Ilb/IIIa receptor in high-risk coronary angioplasty: the EPIC investigation. N Engl J Med. 1994;330: 956-961.
34. Bittl JA. Advances in coronary angioplasty. N Engl J Med. 1996; 335:1290-1302.